2009
DOI: 10.2174/187152309787580829
|View full text |Cite
|
Sign up to set email alerts
|

Analytical Procedure for Determination of Cyclooxygenase-2 Inhibitors in Biological Fluids by High Performance Liquid Chromatography: A Review

Abstract: High-performance liquid chromatographic methods for the analysis of cyclooxygenase 2 inhibitors (COX-2) in biological fluids are reviewed. In particular, sample preparation and handling procedures, chromatographic conditions and detection methods are discussed. A summary of published high-performance liquid chromatographic assays for individual nabumetone, celecoxib, rofecoxib, nimesulide, etoricoxib, etodolac, deracoxib, lumiracoxib, valdecoxib, and meloxicam is included.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 126 publications
(136 reference statements)
0
1
0
Order By: Relevance
“…Non‐steroidal anti‐inflammatory drugs (NSAIDs) can cause adverse drug reactions due to their frequent usage and interaction with a wide range of other medications . Thus, development of efficient and reliable assays to monitor levels of NSAIDs in biological fluids has been extensively studied . Zaltoprofen (ZPF) is an NSAID from the propionic acid family and selectively inhibits the activity of cyclooxygenase‐2, as well as the production of prostaglandin E2 at sites of inflammation .…”
Section: Introductionmentioning
confidence: 99%
“…Non‐steroidal anti‐inflammatory drugs (NSAIDs) can cause adverse drug reactions due to their frequent usage and interaction with a wide range of other medications . Thus, development of efficient and reliable assays to monitor levels of NSAIDs in biological fluids has been extensively studied . Zaltoprofen (ZPF) is an NSAID from the propionic acid family and selectively inhibits the activity of cyclooxygenase‐2, as well as the production of prostaglandin E2 at sites of inflammation .…”
Section: Introductionmentioning
confidence: 99%